Return to Statistics Toolbox

Pathway mapping for Study ST002121

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline (6)
Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml (6)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo